RNF183 and inflammatory bowel disease: Furthermore, miR-7 could reduce the ubiquitination and degradation of NF-κB inhibitor alpha (IκBα) by negatively regulating RING finger protein 183 (RNF183), thereby inhibiting the NF-κB pathway and alleviating the process of IBD [53].